PXD037472 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | GPCR signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics |
Description | G protein-coupled receptors are important drug targets that engage and activate signaling transducers in multiple cellular compartments. Delineating therapeutic signaling from signaling associated with adverse events is an important step towards rational drug design. The glucagon-like peptide-1 receptor (GLP-1R) is a validated target for the treatment of diabetes and obesity, but drugs that target this receptor are a frequent cause of adverse events. Using recently developed biosensors, we explored the ability of GLP-1R to activate 15 pathways in 4 cellular compartments and demonstrate that modifications aimed at improving the therapeutic potential of GLP-1R agonists greatly influence compound efficacy, potency and safety in a pathway- and compartment-selective manner. These findings, together with comparative structure analysis, time-lapse microscopy and phosphoproteomics, reveal unique signaling signatures for GLP-1R agonists at the level of receptor conformation, functional selectivity and location bias, thus associating signaling neighborhoods with functionally distinct cellular outcomes and clinical consequences. |
HostingRepository | PRIDE |
AnnounceDate | 2023-11-14 |
AnnouncementXML | Submission_2023-11-14_08:33:43.843.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Pierre Sabatier |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | phosphorylated residue; acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2022-10-17 01:11:07 | ID requested | |
1 | 2023-10-11 05:44:55 | announced | |
⏵ 2 | 2023-11-14 08:33:44 | announced | 2023-11-14: Updated project metadata. |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: compartmentalized signaling, GLP-1R, functional selectivity, incretin mimetics, adverse drug reactions,GPCR, BRET |
Contact List
Volker M. Lauschke |
contact affiliation | Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany University of Tübingen, Tübingen, Germany |
contact email | volker.lauschke@ki.se |
lab head | |
Pierre Sabatier |
contact affiliation | Department of Surgical Sciences, Uppsala University. Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. |
contact email | pierre63.sabatier@gmail.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/10/PXD037472 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD037472
- Label: PRIDE project
- Name: GPCR signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics